Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):444–449. doi: 10.1097/PAI.0b013e318206d958

Table 2.

Median survival stratified by Pdx1 composite immunohistochemistry score.

Pdx1 expression (composite score) No. of cases Median survival time (months) 95% CI P value*
Pdx1 high (≥4) 54 17.8 11.8–23.9 0.95
Pdx1 low (<4) 13 15.1 9.8–20.4
*

<0.05 is significant.